CrossrefInfokarte
IRF4 transcriptionally activates CD36 to regulate glycolysis and suppress oxaliplatin resistance in colorectal cancer
The Korean Journal of Physiology & Pharmacology · 2026-11-01 · 30 (6) · 641-651
DOI: 10.4196/kjpp.25.448 ↗Abstract
Kein Abstract verfügbar.
EUVIMED